NPs Basic Information
|
Name |
Palmaerone G
|
| Molecular Formula | C11H11ClO4 | |
| IUPAC Name* |
(3R)-7-chloro-6-hydroxy-8-methoxy-3-methyl-3,4-dihydroisochromen-1-one
|
|
| SMILES |
C[C@@H]1CC2=CC(=C(C(=C2C(=O)O1)OC)Cl)O
|
|
| InChI |
InChI=1S/C11H11ClO4/c1-5-3-6-4-7(13)9(12)10(15-2)8(6)11(14)16-5/h4-5,13H,3H2,1-2H3/t5-/m1/s1
|
|
| InChIKey |
SMTOUPGUZZJDSZ-RXMQYKEDSA-N
|
|
| Synonyms |
Palmaerone G
|
|
| CAS | NA | |
| PubChem CID | 139590929 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 242.65 | ALogp: | 2.5 |
| HBD: | 1 | HBA: | 4 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 55.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 16 | QED Weighted: | 0.77 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.706 | MDCK Permeability: | 0.00002300 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.001 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.484 | Plasma Protein Binding (PPB): | 95.55% |
| Volume Distribution (VD): | 0.683 | Fu: | 3.08% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.943 | CYP1A2-substrate: | 0.798 |
| CYP2C19-inhibitor: | 0.399 | CYP2C19-substrate: | 0.462 |
| CYP2C9-inhibitor: | 0.564 | CYP2C9-substrate: | 0.888 |
| CYP2D6-inhibitor: | 0.486 | CYP2D6-substrate: | 0.437 |
| CYP3A4-inhibitor: | 0.335 | CYP3A4-substrate: | 0.162 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 11.797 | Half-life (T1/2): | 0.422 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.322 |
| Drug-inuced Liver Injury (DILI): | 0.739 | AMES Toxicity: | 0.047 |
| Rat Oral Acute Toxicity: | 0.101 | Maximum Recommended Daily Dose: | 0.704 |
| Skin Sensitization: | 0.236 | Carcinogencity: | 0.628 |
| Eye Corrosion: | 0.006 | Eye Irritation: | 0.883 |
| Respiratory Toxicity: | 0.34 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005553 |  |
0.720 | D0C1SF |  |
0.286 | ||
| ENC005703 |  |
0.694 | D07MGA |  |
0.284 | ||
| ENC003934 |  |
0.654 | D07MEH |  |
0.256 | ||
| ENC000757 |  |
0.615 | D0L1JW |  |
0.255 | ||
| ENC002387 |  |
0.585 | D04TDQ |  |
0.243 | ||
| ENC002045 |  |
0.566 | D08SKH |  |
0.236 | ||
| ENC005248 |  |
0.528 | D0J4IX |  |
0.235 | ||
| ENC005249 |  |
0.528 | D0G4KG |  |
0.231 | ||
| ENC000960 |  |
0.528 | D06GCK |  |
0.231 | ||
| ENC004925 |  |
0.473 | D03SKD |  |
0.227 | ||